Latest Soluble fms-like tyrosine kinase-1 Stories
LAGUNA HILLS, Calif., Feb.
New research has identified a potential cause of and a better diagnostic method for preeclampsia, one of the most deadly and poorly understood pregnancy-related conditions in the world.
Cardiologists have discovered biomarkers that can be used to develop a screening test to detect Peripartum Cardiomyopathy (PPCM), a life-threatening disorder that is the primary cause of mortality in pregnant women in developing countries.
Pregnant women who have a reduced number of capillaries under their skin during pregnancy may be at heightened risk for preeclampsia.
Ben-Gurion University of the Negev (BGU) researchers have determined that preeclampsia is a significant risk factor for long-term health issues, such as chronic hypertension and hospitalizations later in life.
Peripartum cardiomyopathy, a form of heart failure that by definition develops late in pregnancy or shortly after delivery, results in a frightening turn of events that can leave new mothers suffering from a lifelong chronic heart condition.
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting ™, in Dallas, Texas, researchers will report findings that indicate that elevated levels of cell-free DNA in the first trimester do not predict the subsequent development of preeclampsia.
Two studies from the Mayo Clinic presented during the American Society of Nephrology's Annual Kidney Week provide new information related to high blood pressure during pregnancy.
A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition â€“ balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.
- A handkerchief.
- In general, any miraculous portrait of Christ.